皮肤黑色素瘤AJCC第7版与第8版生存差异:多中心人群研究
该多中心研究纳入1998至2018年诊断的7815例黑色素瘤患者,用AJCC第7版和第8版分别重新分期并比较总生存。第8版使IB、IIIA、IIIB期患者减少而IA、IIIC期增加,III期新分期患者预后更好,但分期与预后线性关系丧失且组间重叠。
要点
- 第8版AJCC使黑色素瘤I期和III期发生主要分期迁移。
- 第8版分期严重程度线性关系丧失,相邻分期组生存曲线重叠。
- 新分期III期患者预后更好,但更晚期别不一定预后更差。
核心结论
- AJCC第8版黑色素瘤分期较第7版发生重要变化,主要迁移在I期和III期,分期与预后线性关系丧失且组间重叠,更晚期别不意味着更差预后。
研究设计与样本
- 所有患者按AJCC第7版和第8版重新分类,用Sankey图评估版本间迁移,主要结局为总生存(OS),用Kaplan-Meier法比较生存差异。
主要发现
- 第8版中IB、IIIA和IIIB期患者数量减少,而IA和IIIC期患者明显增加。
- 迁移分析显示I期组许多患者被低估分期,而III期组相当比例患者被升级分期。
- 间接OS分析显示第8版AJCC丧失线性关系且组间趋于重叠。
- 直接OS分析显示新分期III期患者预后更好,而I期和II期患者无影响。
临床怎么用
- 临床评估黑色素瘤预后时应注意第8版AJCC分期中I期和III期的迁移及生存曲线重叠现象。
- 不能简单依据更晚期别判断更差预后,需结合第8版分期变化重新评估风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The 8th edition of the AJCC manual for melanoma includes many changes leading to major substage migrations, which could lead to important clinical reassessments. OBJECTIVES: To evaluate the differences and prognostic value of the 8th AJCC classification in comparison with the 7th edition. METHODS: Clinical and histopathological data were retrieved from five melanoma referral centers including 7815 melanoma patients diagnosed between January 1998 and December 2018. All patients were reclassified and compared using the 7th and 8th classifications of the AJCC. Sankey plots were used to evaluate the migration of patients between the different versions. The primary outcome was overall survival (OS), and curves based on the Kaplan-Meier method were used to investigate survival differences between the 7th and 8th editions. RESULTS: The number of patients classified as stages IB, IIIA, and IIIB decreased while the patients classified as stages IA and IIIC increased notably. Migration analysis showed that many patients in group I were understaged whereas a significant percentage of patients in group III were upstaged. Indirect OS analysis showed a loss in the linearity in the AJCC 8th edition and the groups tended to overlap. Direct OS analysis between groups and versions of the AJCC showed a better prognosis within the new stage III patients, with no effect on those in stages I and II. CONCLUSION: The 8th AJCC edition represents an important change in the classification of patients. We observe that the main migratory changes occur in stage I and III, that severity linearity is lost and groups overlap, and that a more advanced stage does not mean a worse prognosis.
引用
- Barreiro-Capurro A, Andrés-Lencina JJ, Podlipnik S, et al. Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study. Eur J Cancer. 2021. PMID: 33418234. doi:10.1016/j.ejca.2020.11.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。